FROM John Rother
America's Wild West of Drug Pricing Earlier this year, when pharma exec Martin Shkreli bought the rights to an old drug and then raised its price 5000%, Americans named him the most hated man in the country. But he is only doing what Big Pharma does everyday thanks to patent laws and America's free market approach to drug pricing. Rising costs are outraging patients, doctors and health insurers all along the political spectrum, but with all the money Big Pharma spends on lobbying, will Washington take up drug pricing reform?
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
Is the threat from Russia missing from the Russia meddling probe? There's much being made about the Trump administration's possible ties with Russia. But the bottom line is Russia's effort to influence American democracy. Do the President and his aides care enough to take action before voters go back to the polls?